Drug Profile
Nicotine transdermal - Acrux
Alternative Names: Nicotine MDTS®; Nicotine Metered Dose Transdermal System; Nicotine Replacement Therapy; NRT - AcruxLatest Information Update: 08 Jan 2022
Price :
$50
*
At a glance
- Originator Acrux
- Class Alkaloids; Analgesics; Drug withdrawal therapies; Nicotine replacement therapy; Pyridines; Small molecules
- Mechanism of Action Nicotinic receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes - Smoking withdrawal
Highest Development Phases
- No development reported Smoking withdrawal
Most Recent Events
- 16 Nov 2020 AMAG Pharmaceuticals has been acquired by Covis Pharma
- 04 Nov 2017 No recent reports of development identified for phase-I development in Smoking-withdrawal in Australia (Transdermal, Spray)
- 12 Nov 2014 Lumara Health has been acquired by AMAG Pharmaceuticals